Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Internal Medicine Specialist
M.B.B.S., MRCGP (UK)
General Physician
MBBS, MRCP(UK)
Internal Medicine Specialist
MBBS, FCPS ( Internal Medicine)
Diabetologist
MBBS, FCPS (Medicine), Fellowship in Endocrinology
Diabetologist
M.B.B.S., M.R.C.G.P.
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures